ABSTRACT. The variable affection of rib and limb growth in human skeletal dysplasias suggests the presence of sitespecific regulatory mechanisms for chondrocyte proliferation. We therefore studied the clonal growth of normal human costal and articular chondrocytes from the same four fetuses (15 to 30 wk of gestation) in a semisolid medium (0.8% methylcellulose) with a basal supplementation of 5% heat-inactivated FCS. IGF-I 10.3-12.5 ng/mL (0.04-1.6 nmol/L)], IGF-I1 10.3-1 2.5 ng/mL (0.04-1.7 nmol/L)], and hGH 10.5-25 ng/mL (0.02-1.1 nmol/L)] stimulated clonal growth of articular and costal chondrocytes without site-specific difference. In contrast, a significant difference was found for transforming growth factor-81, which proved to be a potent growth factor for fetal articular chondrocytes but did not stimulate or only minimally stimulated fetal costal chondrocytes [p < 0.05 for 0. Abbreviations regulation of IGF action (7) (8) (9) . Because IGF-I. IGF-11. and IGFBP have been identified in various human fetal tissues. including the growth plate. an autocrine or paracrine action is supposed ( 10. 1 1 ). In virro studies showed that IGF-I and-even more potent-IGF-I1 are stimulators of human fetal chondrocyte proliferation ( 1 2). Insulin. however. exerted a mitogenic action only at supraphysiologic doses. Therefore. in vivo, the effect of insulin may be indirect via its capacity to regulate IGFBP-I expression ( 13) .
Recently, the family of TGF-8. which now comprises five multifunctional proteins. has received growing interest in the study of chondro-osseal development ( 1 4, 15) . The effects of TGF-81-a 25-kD homodimer-have been studied most extensively; effects on cell differentiation. proliferation, and matrix synthesis have been indicated. The enhanced expression of TGF-@ mRNA in the growth plates of human fetal long bones indicates a role in the regulation of prenatal growth (16) .
In human skeletal dysplasias. ribs and limbs can show a different degree of growth retardation (17, 18) , indicating a sitespecific regulation of chondrocyte proliferation. To test this hypothesis. we studied the effect of IGF-I, IGF-11, hGH. and TGF-81 on clonal growth of articular and costal chondrocytes from four human fetuses. Parallel experiments were performed after preincubation with an IGF-I receptor antibody (oIR-3) to investigate the role of this pathway for the mitogenic action. gested with trypsin (500 U/mL) and collagenase CLS 11 WorSupported in part by grants of the Bundesrninisterium f"r Forschung und thington (300 U/mL. Seromed-Biochrom, Berlin. Germany).
MATERIALS AND METHODS
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After centrifugation. each cell pellet was resuspended in Ham's CLONAL GROWTH OF HUM .4N FETAL CHONDROCYTES 39 1 F-I0 medium supplemented with 10% FCS. 200 mmol/L Lglutamine, and 0.5% minimum essential medium vitamins (Seromed-Biochrom. Berlin. Germany). Viability of cells was tested by the trypan blue exclusion test (22) .
Clonal prol~feration c!f ckondroc~.tes. This assay was performed as previously described (12) . It is based on the observation that. in a semisolid medium. chondrocytes are prevented from sedimentation and therefore proliferate by forming colonies. The chondrocytes retain their differentiated phenotype in this threedimensional culture system. indicated by the expression of collagen I1 (15) . Briefly. 1000 chondroc ytes per Petri dish (9.6 cm'. Greiner, Frickenhausen. Germany) were incubated with BM Whissler Medium (Boehringer Mannheim. Germany) supplemented with 5% heat-inactivated FCS, 0.06 nmol/L netilmicin sulfate. 0.1 mmol/L 2-mercaptoethanol, MEM vitamins, and 0.8% methylcellulose (Fluka. Buchs. Switzerland). The cultures were incubated for 12 d at 37°C in reduced oxygen atmosphere (5% C02. 5% 02, 95% relative humidity). In addition to the basal stimulation with heat-inactivated FCS. various concentrations of IGF-I. IGF-11. hGH, and TGF-P1 were tested. In parallel. the assay was performed in the presence of an IGF-I-receptor antibody at a concentration of 2 x lo-'@ mol/L. In preliminary cxperimenrs. rnis concentration was found to completely suppress the action of IGF-I in the concentrations used. An unspecific antibody purified identically. using a sepharose column. had no stimulatory or inhibitory effect on clonal growth of the chondrocytes. After 12 d. the number of colonies was counted and the results were expressed as a percentage of the basal conditions with 5% heat-inactivated FCS. All experiments were performed in triplicate.
Statistics. Paired r test was used to calculate whether differences exist between the response of articular and costal chondrocytes to the growth factors (SAS statistical program. SAS Institute. Cary, NC).
RESULTS
Influence of IGF-I, IGF-II, hGH, and TGF-PI. Clonal growth of human fetal articular and costal chondrocytes could be stimulated with IGF-I even at the lowest concentration of 0.3 ng/mL (0.04 nmol/L). There was no significant difference in response of rib and limb chondrocytes (Table I ) .
IGF-I1 stimulated clonal growth at the lowest concentration of 0.3 ng/mL (0.04 nmol/L) in chondrocytes from both locations (Table I ). Similar to IGF-I. there was no significant difference between articular and costal chondrocq~es (Table 1) .
hGH stimulated clonal growth of chondrocyte from both locations at the lowest concentration used [0.5 ng/mL (0.02 nmol/L)]. Again. there was no significant difference in the response of articular and costal chondrocytes (Table 1 ) . TGF-PI was a potent growth factor for human fetal articular chondrocytes. Maximal recruitment and subsequent proliferation resulted in a colony incidence of 200 to 220% compared with basal conditions. In contrast. costal chondrocytes were not or were only minimally stimulated by TGF-PI under the same experimental conditions (Table I ) . Table 2) .
Preincilbation 1i.ith an IGF-I receptor antibod). (aIR-3). Prein
DISCUSSION
Clonal growth is characteristic for chondrocytes in vivo and in vitro (23. 24) . We therefore I I~? an assay system thl! messures the development of colonies out of single cells to test the hypothesis of a differential regulation of cell proliferation in fetal rib and limb cartilage. We provide direct evidence for such a regulatory difference because TGF-8 1 was a potent growth factor for human fetal articular chondrocytes but did not stimulate. or only minimally stimulated. costal chondrocytes. These results are interesting in two regards. First. they clearly show that regulation of fetal growth during midterm ( 15th to 30th wk of gestation) is site-specific and involves the responsiveness of the target tissue to TGF-P1. Secondly. it is important to point out that, under our experimental conditions. the potency of TGF-PI even slightly exceeded that of IGF-I or IGF-I1 in the case of human fetal articular chondrocytes.
Previous animal studies indicated that TGF-81 may have a role in vertebrate limb development (25.26) . The high expression of TGF-8 in growth plates of human fetal long bones (16) and its ability to stimulate clonal growth of isolated human fetal articular chondrocytes as shown here suggest an additional role for the regulation of skeletal growth of the human fetus.
The signal for the induction of cell proliferation in chondrocytes by TGF-P1 does not seem t o involve IGF-I. inasmuch as IGF-I was not induced in postnatal rabbit articular chondrocytes by TGF-81 (27) . Our results. however, show that in human fetal articular chondrocytes the action of TGF-01-at least in the lower concentration used-can be partially reduced by preincubation with the IGF-I-receptor antibody. This apparent discrep ancy may be explained by induction of IGF-I1 or by differences between postnatal rabbit and fetal human chondrocytes in IGF-I stimulation. Another possible explanation is that the proliferative affect of TGF-PI on chondrocytes is modulated by serum factors, one of which is epidermal growth factor (28, 29) . Because IGF peptides are produced by the chondrocyte itself (lo), they might be additional factors that partly enhance TGF-PI action on clonal growth of human fetal articular chondrocytes.
The reason for the different effect of TGF-PI on human fetal articular and costal chondrocytes remains unknown so far. One possible explanation may be site-specific differences in TGF-P receptors that have been demonstrated in chondrocytes of different zones of the chicken articular growth plate (30) .
Colony formation in response to IGF-I and IGF-I1 was not significantly different in chondrocytes of rib or articular origin, although articular chondrocytes of younger fetuses responded slightly better. A higher number of samples has to be studied to prove or exclude a different age-dependent response to these growth factors. The proliferative effect of IGF-I and IGF-I1 could be completely prevented by preincubation with the IGF-I receptor antibody. This clearly shows that their effect on clonal growth of human fetal chondrocytes is mediated via this type of receptor.
In contrast to the growing evidence that hGH plays only a minor role in fetal skeletal growth in vivo, hGH stimulated growth of fetal chondrocytes in our assay system even at low concentration. This apparent discrepancy may be based on an increase of growth hormone receptor expression by growth hormone itself during the in vitro assay as observed in the mRNA level in postnatal rat chondrocytes (3 1). Thus, our results show that human fetal chondrocytes have the ability to respond to hGH under the cell culture conditions applied. However, this might not reflect the in vivo situation. The stimulation of clonal growth by hGH could be completely prevented by preincubation with the IGF-1-receptor antibody. This clearly confirms the nntion th2t the ohserved eflect nf hGH on clonal growth is due to paracrine induction of IGF. Whether hGH additionally stimulates differentiation of human fetal prechondrocytes directly according to the dual effector theory (32) remains an open question.
